Skip to main content

Table 3 Average cost per woman in € included in the study from the time of inclusion to the end of the follow-up period at delivery

From: Effectiveness and costs of non-invasive foetal RHD genotyping in rhesus-D negative mothers: a French multicentric two-arm study of 850 women

Cost centre

Genotyping

Controls

p value

n = 515

n = 335

Costs relating to RHD - status

 Biological tests - Genotyping, IAT, Kleihauer

268 ± 74

105 ± 49

< 0,001

 Anti-D immunoglobulin injections

136 ± 86

136 ± 57

0.94

 Consultations

187 ± 79

211 ± 76

< 0,001

 Total costs related to RHD status

591 ± 113

452 ± 124

< 0,001

Hospital stay costs

 Hospital admissions during pregnancy

262 ± 910

280 ± 844

0.36

 Delivery

2406 ± 469

2272 ± 477

< 0,001

 Total costs relating to hospital stays

2668 ± 1101

2552 ± 984

0.95